Literature DB >> 30701532

HIV-1 Tat protein induces aberrant activation of AICDA in human B-lymphocytes from peripheral blood.

Fatimata Bintou Sall1,2, Rawan El Amine1,2, Diana Markozashvili3, Tatyana Tsfasman1,2, Eric Oksenhendler4, Marc Lipinski1,2, Yegor Vassetzky1,2,5, Diego Germini1,2.   

Abstract

Individuals infected with human immunodeficiency virus (HIV) are at increased risk for Burkitt lymphoma, a B-cell malignancy which occurs after a chromosomal translocation rearranging the MYC oncogene with an immunoglobulin gene locus, usually the IGH heavy chain gene locus. We have previously reported that the HIV protein Tat which circulates in all HIV-positive individuals whatever their immune status caused an increased rate of colocalization between IGH and MYC in B-cells nuclei. We here present in vitro evidence that Tat activates the expression of the AICDA gene that encodes the activation-induced cytidine deaminase whose physiological function is to create double-strand breaks for immunoglobulin gene maturation. In the presence of Tat, DNA damage was observed concomitantly in both MYC and IGH, followed by DNA repair by nonhomologous end joining. AICDA was further found overexpressed in vivo in peripheral blood B-cells from HIV-infected individuals. Thus, the capacity of Tat to spontaneously penetrate B-cells could be sufficient to favor the occurrence of MYC-IGH oncogenic rearrangements during erroneous repair, a plausible cause for the increased incidence of Burkitt lymphoma in the HIV-infected population.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  B-cell; IGH; activation-induced cytidine deaminase (AID); human immunodeficiency virus-1 (HIV-1) Tat; oncogenesis

Year:  2019        PMID: 30701532     DOI: 10.1002/jcp.28219

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  4 in total

Review 1.  HIV Lymphoma and Burkitts Lymphoma.

Authors:  Ariela Noy
Journal:  Cancer J       Date:  2020 May/Jun       Impact factor: 2.074

2.  HIV-1 Tat Activates Akt/mTORC1 Pathway and AICDA Expression by Downregulating Its Transcriptional Inhibitors in B Cells.

Authors:  Burkitkan Akbay; Diego Germini; Amangeldy K Bissenbaev; Yana R Musinova; Evgeny V Sheval; Yegor Vassetzky; Svetlana Dokudovskaya
Journal:  Int J Mol Sci       Date:  2021-02-04       Impact factor: 5.923

3.  HIV-1 Transactivator of Transcription (Tat) Co-operates With AP-1 Factors to Enhance c-MYC Transcription.

Authors:  Leonardo Alves de Souza Rios; Lungile Mapekula; Nontlantla Mdletshe; Dharshnee Chetty; Shaheen Mowla
Journal:  Front Cell Dev Biol       Date:  2021-06-30

4.  Modulation of Cellular MicroRNA by HIV-1 in Burkitt Lymphoma Cells-A Pathway to Promoting Oncogenesis.

Authors:  Beatrice Relebogile Ramorola; Taahira Goolam-Hoosen; Leonardo Alves de Souza Rios; Shaheen Mowla
Journal:  Genes (Basel)       Date:  2021-08-24       Impact factor: 4.096

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.